Volgen
meike de wit
meike de wit
Department of Pathology, the Netherlands cancer institute, Amsterdam
Geverifieerd e-mailadres voor nki.nl
Titel
Geciteerd door
Geciteerd door
Jaar
SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas
K Magnusson, M de Wit, DJ Brennan, LB Johnson, SF McGee, ...
The American journal of surgical pathology 35 (7), 937-948, 2011
2362011
TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression
AH Sillars-Hardebol, B Carvalho, M Tijssen, JAM Beliën, M de Wit, ...
Gut 61 (11), 1568-1575, 2012
1482012
The role of SATB2 as a diagnostic marker for tumors of colorectal origin: results of a pathology-based clinical prospective study
A Dragomir, M de Wit, C Johansson, M Uhlen, F Pontén
American journal of clinical pathology 141 (5), 630-638, 2014
1252014
The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context
TBM Schaaij-Visser, M De Wit, SW Lam, CR Jiménez
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1834 (11), 2242-2258, 2013
1212013
Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications
M de Wit, RJA Fijneman, HMW Verheul, GA Meijer, CR Jimenez
Clinical biochemistry 46 (6), 466-479, 2013
1092013
Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression
AH Sillars-Hardebol, B Carvalho, M de Wit, C Postma, ...
Tumor Biology 31 (2), 89-96, 2010
1032010
Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling
M de Wit, H Kant, SR Piersma, TV Pham, S Mongera, MPA van Berkel, ...
Journal of proteomics 99, 26-39, 2014
942014
Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression
M de Wit, CR Jimenez, B Carvalho, JAM Belien, PM Delis-van Diemen, ...
Gut 61 (6), 855-864, 2012
872012
Whole gel processing procedure for GeLC-MS/MS based proteomics
JCR Piersma SR, Warmoes MO, de Wit M, de Reus I, Knol
Proteome Sci. 11 (17), 2013
852013
Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression
J Albrethsen, JC Knol, SR Piersma, TV Pham, M de Wit, S Mongera, ...
Molecular & Cellular Proteomics 9 (5), 988-1005, 2010
852010
Proximal Fluid Proteome Profiling of Mouse Colon Tumors Reveals Biomarkers for Early Diagnosis of Human Colorectal CancerProximal Fluid Proteome Profiling Reveals CRC Biomarkers
RJA Fijneman, M De Wit, M Pourghiasian, SR Piersma, TV Pham, ...
Clinical Cancer Research 18 (9), 2613-2624, 2012
702012
Lumican and versican are associated with good outcome in stage II and III colon cancer
M de Wit, EJT Belt, PM Delis-van Diemen, B Carvalho, VMH Coupé, ...
Annals of surgical oncology 20 (3), 348-359, 2013
492013
BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain
AH Sillars‐Hardebol, B Carvalho, JAM Beliën, M de Wit, ...
The Journal of pathology 226 (3), 442-450, 2012
462012
Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer
N Snoeren, BL Emmink, MJG Koerkamp, SR van Hooff, JACM Goos, ...
British journal of cancer 109 (6), 1636-1647, 2013
442013
MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients
K Lenos, JACM Goos, IM Vuist, H Sjoerd, PM Delis-van Diemen, JT Eric, ...
Oncotarget 6 (28), 26278, 2015
382015
Novel stool-based protein biomarkers for improved colorectal cancer screening: a case–control study
LJW Bosch, M De Wit, TV Pham, VMH Coupé, AC Hiemstra, SR Piersma, ...
Annals of Internal Medicine 167 (12), 855-866, 2017
322017
CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression
AH Sillars-Hardebol, B Carvalho, JAM Beliën, M de Wit, ...
Cellular Oncology 35 (4), 293-300, 2012
272012
Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression
M de Wit, B Carvalho, PM Delis-van Diemen, C van Alphen, JAM Beliën, ...
PLoS One 12 (5), e0174768, 2017
262017
Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression
MA Komor, M de Wit, J van den Berg, SR Martens de Kemp, ...
International journal of cancer 146 (7), 1979-1992, 2020
232020
Peptide-mediated ‘miniprep’isolation of extracellular vesicles is suitable for high-throughput proteomics
JC Knol, I de Reus, T Schelfhorst, R Beekhof, M de Wit, SR Piersma, ...
EuPA open proteomics 11, 11-15, 2016
232016
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20